← Leaderboards
Ratna Chakrabarti
University Of Central Florida
$686,682
Attributed
$686,682
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $213K · FY2008–20$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$686,682 · 3
By mechanism
R21$473,682 · 2
R15$213,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Central Florida
Same institution · by research overlap
- Debopam Chakrabarti$8,457,429
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationCancer CellNuclearSignal TransductionPlayMalignant NeoplasmsInnovationMessenger RnaProteinsResponseResistanceRefractoryPharmaceutical PreparationsAreaEctopic ExpressionGrowthArchitectureAffectApoptosisBiologicalCell LineCell MotilityBiochemicalAndrogen Sensitive
Grant awards (4)
Implication of a novel long noncoding RNA in therapy resistant prostate cancer with altered AR signaling$166,296
R21 · FY2020 · CA · contact PI
Implication of a novel long noncoding RNA in therapy resistant prostate cancer with altered AR signaling$198,703
R21 · FY2019 · CA · contact PI
LIM kinase 1 and Cell Cycle Regulation$213,000
R15 · FY2008 · CA · contact PI
MOLECULAR MARKERS FOR PROSTATE CANCER$108,683
R21 · FY2000 · CA